Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

Psoriasis increases annual healthcare costs by $4,044 per patient, with biologic treatments costing significantly more than phototherapy.

This study reported that women with alopecia often face high out-of-pocket costs for over-the-counter treatments and camouflaging agents due to insufficient insurance coverage, which can significantly impact their financial well-being and ability to afford basic necessities.

Organizations help patients access discounts for expensive dermatology medications.

Discount pharmacies offer cheaper options for hair loss medications than traditional or direct-to-consumer pharmacies.

This article examines why a major health care system's patients cannot access Wal-Mart's low price for finasteride, despite broader availability, due to complex industry and policy factors, without reporting new clinical results.

This study found that patients with alopecia areata had similar total health care costs as those with atopic dermatitis, despite having fewer comorbidities and prescription medications overall.

This study found that individuals with alopecia areata in Germany, Austria, and Switzerland face significant out-of-pocket costs averaging 1,248€ annually, primarily for hair replacement products and cosmetics.

This study found that urologist prescription practices for three common conditions led to nearly $410 million in excess Medicare Part D spending on higher cost and non-generic drugs in 2014.

The researchers reported that using GoodRx.com enables patients to find the most affordable options for purchasing finasteride, a medication often not covered for androgenic alopecia, by comparing prices at local and mail order pharmacies in Washington, D.C.

Scalp cooling therapy is costly and often not covered by insurance, limiting access for low-income patients.

This study found that CPA-loaded nanoparticles, particularly SLN formulations, increased CPA epidermal penetration compared to a conventional cream and may reduce side effects in treating androgen-dependent conditions.

This article reviews the potential applications of Point of Care procedures in radiology, discussing their ability to enhance the speed of diagnosis and treatment but does not report new results.

This study found that big chain pharmacies in Pennsylvania charged significantly higher prices for generic BPH medications compared to independent pharmacies, which had more regional price variation.

This study reports that patients with alopecia areata in the US incur significantly higher healthcare utilization and expenses, primarily driven by ambulatory and pharmacy costs, compared to matched controls.

This study examined the market trends for biologics that have lost patent exclusivity and predicted that drugs like adalimumab, once facing competition, could see price reductions and decreased market share, although the impact on accessibility and total patient use remains unclear.

Many patients miss follow-ups due to financial issues, no insurance, transport problems, and time limits.

This study observed that the out-of-pocket prices for generic medications used to treat benign prostatic hyperplasia can vary by up to 500% among pharmacies in the Pittsburgh area, with chain pharmacies pricing significantly higher than independents.

Cataract surgery in Europe varies in frequency and cost between countries.

This study found that independent pharmacies in the St. Louis metropolitan area offer significantly lower prices for certain generic urologic medications compared to chain pharmacies, regardless of geography or zip code income.

This study found that middle-aged patients, patients in certain geographical regions, and female patients of specific age groups with alopecia areata face higher medical costs, indicating significant financial variability for affected subgroups.

This CADTH recommendation advises that Olumiant should be publicly reimbursed for treating severe alopecia areata in adults, provided conditions such as a 50% scalp hair loss and specific prescribing criteria are met.

This study found that 10% carbamide peroxide significantly reduced acne lesions compared to a vehicle solution, suggesting it as an effective and safe alternative to benzoyl peroxide for treating mild to moderate acne.

This study found that psoriasis patients had a significantly higher prevalence of autoimmune diseases and other comorbidities compared to those without psoriasis.

This study reported that despite the limited effectiveness of many current therapies for alopecia areata, patients face substantial financial burdens managing the condition, based on an analysis of ten studies involving approximately 16,000 patients.

This study found that compliance rates for oral contraceptives are low and similar to those for other medical treatments, indicating a need for alternatives that require less daily adherence.

This study found that patients on dutasteride had $20.50 lower monthly medical costs compared to those on finasteride.

Treating chronic hand eczema costs about the same in statutory and occupational health insurances in Germany, but work-related cases may lead to higher indirect costs due to longer work absences.